Enfusion is a pioneer in developing innovative, native cloud investment management software, analytics, and managed services for asset managers and hedge funds around the globe. We underpin the investment operations of fund managers from our global offices spanning four continents. Our unique, seamless, SaaS-based platform is reshaping the global investment operations landscape by removing traditional information boundaries and uniting the front-, middle- and back-office into one system, with one unified data set.
Passionate about client service, we complement our software solutions with expert middle- and back-office managed services. In fact, we've been recognized as Best Managed Services Provider at the HFM EU Services Awards. We help fund managers around the world streamline their operations, mitigate risk, and improve transparency and reporting so they can confidently focus on what they do best – invest.
As a company, we’re absolutely committed to the growth, development, and well-being of our people. Enfusion is where you can pursue your passion, showcase and further develop your skills, and launch a meaningful and rewarding career. If you're looking for a culture that is inclusive, collaborative, entrepreneurial, values diversity, fosters and rewards creative exploration, and strives to continually exceed client expectations then we're looking forward to hearing from you.
The Team:
The OEMS Product Support Organization provides client facing support assisting clients to utilize the Enfusion OEMS module for their daily trading operations. The OEMS Product Support Organization consists of three verticals – Product Specialists, FIX Operations, and Trade Compliance.
The Role:
The OEMS Trade Compliance position plays a critical role in the initial setup and configuration of new clients onto the Enfusion platform with an focus on pre and post trade compliance rules. The team will also troubleshoot existing client compliance rules and test new rule creations.
What You’ll Do:
- Prepare compliance rules across the full investment lifecycle (both pre and post-trade)
- Setup new rules, perform internal testing with appropriate test cases & troubleshoot rule queries on client’s compliance rule requirement
- Comprehensive rule creation functionality applicable at any level of the portfolio/fund hierarchy
- Manage pre- and post-trade as well as end-of-day compliance checks
- Discussion with client on compliance rules requirement
- Knowledge about Buy-side OMS systems will be preferable
What You’ll Need:
- Bachelor’s degree in Finance, Accounting, Economics, Financial Math or related field
- 1-3 years of experience in Middle Office support role at a Hedge Fund, Prime Broker or Fund Administrator
- Financial domain knowledge: Foreign Exchange (FX), NDFs, Derivatives (Interest Rates Swaps/Credit Default Swaps), Equities, Fixed Income and Options
- JavaScript and Jenkins experience a plus
- Detail-oriented and analytical
- Ability to handle and prioritize multiple tasks and work independently
- Excellent verbal and written communication skills
#LI-AB1
Enfusion offers a competitive compensation and benefits package, retirement and pension plans, and generous Paid Time Off policy; and paid parental leave. Other perks include commuter benefits, and an employee assistance program. All benefits and programs are subject to applicable eligibility requirements.
Enfusion is fully committed to providing equal employment opportunity to job applicants and employees in recruitment, hiring, employment, compensation, benefits, promotions, transfers, training, and all other terms and conditions of employment. Enfusion will not discriminate on the basis of age, race, color, gender, marital status, sexual orientation, gender identity, pregnancy, national origin, religion, veteran status, physical or mental disability, genetic information, creed, citizenship or any other status protected by laws or regulations in the locations where we do business. We endeavor to maintain a drug-free workplace.
Position will remain open until filled.
•
Last updated on Aug 28, 2024